Atrial natriuretic peptide clearance inhibitors which resist deg

Details Atrial natriuretic peptide clearance inhibitors which resist deg Atrial natriuretic peptide clearance inhibitors which resist deg

1992-02-20

1995-09-12

Lee, Lester L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 13, 514 14, 514 15, 514 16, 514 12, 530324, 530325, 530326, 530327, 530328, C07K 706, C07K 708, C07K 710

Patent

active

054496624

ABSTRACT:
Compounds with natriuretic, diuretic and/or vasodilation activity which enhance the function of an endogenous ANP are provided. These compounds are capable of both binding to the clearance receptors for ANP and of inhibition of endopeptidase 24.11, an enzyme believed responsible for ANP clearance.

REFERENCES:
patent: 4513009 (1985-04-01), Roques et al.
patent: 4610816 (1986-09-01), Berger
patent: 4740499 (1988-04-01), Olins
patent: 4749688 (1988-06-01), Haslanger et al.
patent: 4757048 (1988-07-01), Lewicki et al.
patent: 4804650 (1989-02-01), Lewicki et al.
patent: 5047397 (1991-09-01), Scarborough et al.
Schiller et al., Biochem. Biophys. Res. Commun. (1987) 143(2):499-505.
Roques, B. P., et al., Nature, 288: 286-288, 1980.
Seymour, A. A., et al., Life Sciences, 43: 2265-2274, 1988.
Farrington, G. K., et al., J. Med. Chem., 32: 737-739, 1989.
Seymour, A. A., et al., Hypertension, 14(1): 87-97, Jul. 1989.
Johnson, G. R., et al., J. Biol. Chem., 264 (20): 11637-11642, Jul. 15, 1989.
Krieter, P. A., J. of Pharm. and Exper. Therap., 249(2): 411-417, 1989.
Deschodt-Lanchman, M., et al., Chem. Abs., 109: 32732a, 1988.
Murthy, K. K., Biochem. J., 240: 461-469, 1986.
Kenny, A. J., et al., Chem. Abs., 108(25): 216409m, Jun. 1988.
Bertrand, P., et al., Biochemical Pharmacology, 37(20): 3817-3821, 1988.
Olins, G. M., et al., FASEB J., 2: A937, 1988.
Patton, D. R. et al., FASEB J., 2: A937, 1988.
Maack et al., Science (1987) 238:675-679.
Fennell et al., FASEB J. (1988) 2:A936.
Seymour et al., FASEB J. (1988) 2:A936.
Stephenson al., Biochem. J. (1987) 243:183-187.
Trapani et al., FASEB J. (1988) 2:A936.
McMartin et al., FASEB J. (1988) 2:A936.
Zimmerman et al., FASEB J. (1988) 2:A937.
Waksman et al., Biochem. Biophys. Res. Comm. (1985) 131:262-268.
Bourgoin et al., J. Pharm. Exp. Ther. (1986) 238:360-366.
Olins et al., Biochem. Biophys Acta (1987) 901:97-100.
Koehn et al., J. Bio. Chem. (1987) 262:11623-11627.
Yandle et al., Biochem. Biophys. Res. Comm. (1987) 146:832-839.
Roques et al., Nature (1980) 288:286-288.
Gordon et al., Life Science (1983) 33: (supplemental 1) :113-116.
Fournie-Zaluski et al., J. Med. Chem. (1983) 26:60-65.
Koepke et al., FASEB J. (1988) 2:A527.
Mumford et al., Biochem. Biophys. Res. Comm. (1982) 109: 1303-1309.

Affiliated with

Also associated with

Rating

Atrial natriuretic peptide clearance inhibitors which resist deg does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Atrial natriuretic peptide clearance inhibitors which resist deg, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Atrial natriuretic peptide clearance inhibitors which resist deg will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-405349